Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Shares Traded Last Trade
  -10.20 -7.74% 121.50 3,717,279 16:35:19
Bid Price Offer Price High Price Low Price Open Price
121.00 121.50 134.20 120.30 131.30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 591.92 135.73 13.57 8.8 891
Last Trade Time Trade Type Trade Size Trade Price Currency
17:48:51 O 1,839 121.50 GBX

Indivior (INDV) Latest News (1)

More Indivior News
Indivior Takeover Rumours

Indivior (INDV) Discussions and Chat

Indivior Forums and Chat

Date Time Title Posts
05/8/202017:08INDIVIOR THE PILL WITH NO CHEERS OR BEERS2,938
09/3/202010:34RB. de-merger 548
11/7/201908:29Johnson & Johnson court case oklahoma6
03/5/201910:16Judgement against insys2
31/7/201813:45Indivior (INDV) IP Battle Status -

Add a New Thread

Indivior (INDV) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:30:27121.501,8392,234.39O
16:50:41121.641,7832,168.84O
16:33:09126.682,3002,913.64O
16:08:38122.3065,16379,691.74O
15:56:41123.613,6474,508.02O
View all Indivior trades in real-time

Indivior (INDV) Top Chat Posts

DateSubject
05/8/2020
09:20
Indivior Daily Update: Indivior Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 131.70p.
Indivior Plc has a 4 week average price of 77.15p and a 12 week average price of 45.52p.
The 1 year high share price is 165.10p while the 1 year low share price is currently 32.90p.
There are currently 733,484,840 shares in issue and the average daily traded volume is 3,304,286 shares. The market capitalisation of Indivior Plc is £891,184,080.60.
30/7/2020
16:23
waldron: Indivior in the red as opioid addiction treatment continues to lose market share to generics By BFN News | 08:54 AM | Thursday 30 July, 2020 Factsheet Indivior Plc Ord USD0.10 (INDV) Pharmaceutical company Indivior swung to a loss in the first half of the year after revenue declined by a third as the company's Suboxone film continue to lose market share to generics. For the six months ended 30 June, the company reported a pre-tax loss of $145m, compared with a profit of $163m on-year as revenue fell 33% to $303m. Suboxone film market share during H1 2020 averaged 22%, down from 38% on-year. Suboclade revenue jumped to $58m from $28m. Looking ahead, the company warned of a 'significant' reduction in Suboxone film revenue as a result of market share loss 'reaching historical industry analogues and negative channel mix.' Suboclade, meanwhile, was expected to see 'modest' growth in new patient enrollments compared with Q2 exit levels, it added. At 8:54am: (LON:INDV) Indivior Plc share price was +2p at 137.5p Story provided by StockMarketWire.com
18/6/2020
15:42
thaiger: Weldon, agreed there's no new news but investors have to listen to share price....there must be someone who knows....or lots of gambling American! ADR at 5 =278p, ADR at 10 = 139p....if $17.26 held!!
17/6/2020
17:28
steeplejack: I was a Member of the London Stock Exchange in my younger days but I’m still amused by how analysts tinker with their target prices all the while baffling the public with discounted cash flow models,suggested PE relatives.Its all smoke and mirrors ......I know,I was one of them once! As a rule of thumb If the TP is 20% above the current share price,the stock will be described as a “buy”,if the TP is 20% below a “sell” and anything in between a varying degree of “hold”...but then then there are speculative buys or long term buys and varying degrees of “sell”.All might be described as different varieties of worm dangling on the end of the brokers rod as he fishes for business.
17/6/2020
17:05
baddeal: SteeplejackBroker recommendations, buy hold etc are normally a function of where the actual share price is relative to their valuation target price. If the gap is small, as in this case with tp of 79p and actual around 70p then likely to be a hold recommendation. If gap is large likely to be a buy rating or sell if tp is below actual share price.... least this is how my old broker explained it to me once
17/6/2020
13:45
steeplejack: So.....sorry,how does this work?The broker has a target price of 39p.....the share price rises to the mid 70s and the insightful broker then raises his target price to 70p.This seems to confirm that financial commentators are more reactive than predictive but maybe I'm cynical.
29/3/2020
10:39
sniffer2: Well Goldman Sachs have been accumulating. Also recent director purchases. They may well know something. They may also be involved in financing any potential deal. The court case is priced into the current share price, so if it settles before, this will rocket. In my experience of trials, around 90% never actually make it to trial. Minds get very focused on the run up and most cases tend to settle weeks before trial. People will have inside knowledge of the legal process, so any increase in purchases may indicate resolution.
04/12/2019
15:45
3rd eye: From the Motley Fool.......... Tom Rodgers: Indivior Opioid drug addiction treatment manufacturer Indivior (LSE: INDV) settled its legal woes this past summer and now its future now looks brighter than bright, in my opinion. Investors can also pick up shares for a song: the firm is forecast to grow its earnings by more than 16% next year and I think it is hugely undervalued. City analysts agree with me, saying the INDV share price could be as much as 93% lower than its true value. Return on equity is a whopping 84.5%, too. I say it’ll be a bumper year ahead for this stock.
01/12/2019
08:48
sarkasm: timmy you got a link for that what$$$$$$$$$$$$$$$$$$$$$$ settled its legal woes this past summer timmy11 1 Dec '19 - 08:39 - 2281 of 2281 0 0 0 Tom Rodgers: Indivior Opioid drug addiction treatment manufacturer Indivior (LSE: INDV) settled its legal woes this past summer and now its future now looks brighter than bright, in my opinion. Investors can also pick up shares for a song: the firm is forecast to grow its earnings by more than 16% next year and I think it is hugely undervalued. City analysts agree with me, saying the INDV share price could be as much as 93% lower than its true value. Return on equity is a whopping 84.5%, too. I say it’ll be a bumper year ahead for this stock. Tom Rodgers has no position in Indivior. EDIT NOT TO WORRY, I FOUND IT LOL Https://www.fool.co.uk/investing/2019/12/01/top-shares-for-december-2019/
01/12/2019
08:39
timmy11: Tom Rodgers: Indivior Opioid drug addiction treatment manufacturer Indivior (LSE: INDV) settled its legal woes this past summer and now its future now looks brighter than bright, in my opinion. Investors can also pick up shares for a song: the firm is forecast to grow its earnings by more than 16% next year and I think it is hugely undervalued. City analysts agree with me, saying the INDV share price could be as much as 93% lower than its true value. Return on equity is a whopping 84.5%, too. I say it’ll be a bumper year ahead for this stock. Tom Rodgers has no position in Indivior.
04/7/2019
15:21
sarkasm: jonsols 4 Jul '19 - 07:34 - 1284 of 1285 0 0 0 Hmmm. Share price is based on future earnings. Regardless of whether INDV has or as not made provision in the books the share price includes a discount for the risk of adverse outcome. Single question for me is whether the market has under or over cooked the discount relative to the most likely outcome at this stage. Not an easy one to adjudge without intimate inside knowledge I would think... mwainw1973 4 Jul '19 - 14:37 - 1285 of 1285 0 0 0 So share price is not influenced by results? LOL In my opinion the share price is influenced by all things depending on the day Results,charts,news broker recommendation, trumptweets and the full moon not so much by whats posted here it being an illiquide share perhaps even the market makers hold sway
Indivior share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
INDV
Indivior
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200805 23:46:54